• Premier Health (PHA) announced a 245-per-cent-increase in revenue for the second quarter of 2021
  • The company filed its condensed interim consolidated financial statements
  • The company generated revenues of $17.0 million for the quarter
  • The company attributes the increase to its full consolidation of the Code Bleu acquisition and organic growth
  • Premier Health is up 2.21 per cent, trading at $1.39 at 2:48 pm ET

Premier Health (PHA) announced a 245-per-cent-increase in revenue for the second quarter of 2021.

The Canadian healthtech company filed its condensed interim consolidated financial statements.

The company generated revenues of $17.0 million for the quarter ($30.4 million for the 6-month period compared to $8.2 million for the same period in 2020).

The company attributes the increase to its full consolidation of the Code Bleu acquisition and organic growth.

“The March offering and the latest technology roll out puts us in a very enviable position to act as an aggregator in our market,” said Premier Health CEO Martin Legault.

Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of outsourced services solutions for healthcare needs to governments, corporations, and individuals.

Premier Health is up 2.21 per cent, trading at $1.39 at 2:48 pm ET.

More From The Market Online

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.

WELL Health and Microsoft to future-proof North American healthcare

WELL Health Technologies (TSX:WELL) and Microsoft (NDAQ:MSFT) sign a five-year deal to expedite healthcare's transition into the digital age.